by the inception of coronary care units. In the past several years, however, increasing attention has been focused on the prehospital phase;'-10 recent studies indicate that two thirds of the deaths from acute myocardial infarction occur outside the hospital, and nearly one half of these deaths are sudden and unexpected, occurring within 2 hours after the onset of symptoms.1-17 The cause of death in the vast majority of patients was presumed to be ventricular fibrillation," 2, 7, 18-21 which was found to be 10 to 20 times more likely to develop during the first 4 hours after onset than it was between 4 and 24 hours after onset. It was further observed that patients with known coronary artery disease and with certain high-risk factors may have a greater chance of dying suddenly.7, 11, 14-17, [22] [23] [24] [25] [26] [27] Many lives have already been saved outside the hospital by mobile coronary care units (MCCU) and mobile intensive care units (MICU); they have made possible the prompt institution of prophylactic and resuscitative measures for the prevention and treatment of the life-threatening cardiac arrhythmias that occur during the early stage of acute myocardial infarction.1 5, [28] [29] [30] [31] [32] [33] [34] [35] [36] Furthermore, preliminary results obtained from a small number of patients indicate that the hospital mortality rate of those who were treated in the first 2 hours after onset of symptoms was impressively lower than those who received care after more than 2 hours of chest pain. 1 This initial observation was subsequently confirmed by other works.5 36 It would seem to be of paramount importance, therefore, to emphasize prompt medical care during this critical prehospital phase.
The term "prehospital care" is defined as the preventive and therapeutic measures rendered to patients with suspected or proven acute myocardial infarction during the interval between the onset of the disease and their arrival at a hospital equipped to provide definitive medical care. Several approaches to the delivery of early care are currently being studied. Different communities will probably find only certain of these approaches applicable, depending upon their resources, manpower, facilities, and capabilities. The three major problems of prehospital care that must be overcome by these approaches are delays in reaching medical care, unavailability of local emergency facilities, and lack of data on the mechanisms of and possible preventive measures against sudden death.
A. To Shorten the Delay in Securing Medical Care
The delay in instituting definitive medical care to a patient with suspected or proven acute myocardial infarction may be attributable to several major factors: the disease itself, the patient, the physician, transportation, and receiving areas.7 ' 8, 10, 16, 31, 37-39 Delay due to the Disease Itself. The first delay in some cases takes place between the onset of acute myocardial infarction and the development of symptoms that may not be appreciated or recognized by the patient himself. In a small number of patients with socalled silent myocardial infarction, symptoms are absent or so mild as to be unrecognizable, and in some patients death is so sudden that symptoms must have been short-lived or even absent.
Patient Factors. In most cases, when symptoms are experienced, delay in seeking medical help is the result of the patient's own indecision, which may be related to: (a) lack of information concerning the significance and importance of the symptoms; (b) fear and denial that the chest pain may actually signal a heart attack; (c) misinterpretation of the chest pain as a symptom of indigestion or disorder of another organ system; (d) reluctance to call his physician or a hospital during an inconvenient time such as night or weekend; or (e) lack of encouragement or assistance from his family members, friends, or co-workers in seeking medical help. Physician Factors. In one study of 100 randomly selected patients, it was found that physicians contributed to patient delay in 12% of the cases.38 Certain physicians may not be familiar with the logistics and community facilities provided for prompt medical care of their patients. A small number of physicians may think that there is little they can do for the patient with acute myocardial infarction. Symiiptoms vary but these are the isual warnings of heart attack: -Prolonged heavy pressure or squeezing pain in the center of chest, behind the breastbone. -Pain may spread to the shoulder, arm, neck or jaw.
-The pain or discomfort is often accompanied by sweating. Nausea, vomiting and shortness of breath may also occur.
-Sometimes these symptoms subside and then return. Don't wait. Act immediately. 20 arrived at the dispensary within 1 hour after the onset of their symptoms. Most patients apparently knew that they were having a heart attack but rationalized away their need for early medical care. Denial has not appeared to be as significant a factor. Ventricular premature contractions (VPCs) were observed in over 70% of the patients during the first 2 lhoirs of Avionic tape recording. Twelve patients developed major ventricular tachyarrhythmias in the first 24 hours of their illness, including two with ventricular fibrillation and three with ventricular tachycardia. One patient who developed ventricular fibrillation upon arrival at the dispensary was successfully resuscitated. In general, patients with major ventricular tachyarrhythmias were found to have higher blood cortisol levels and more frequent closely coupled VPCs than those without tachyarrhythmias.
Since most large factories or industrial firms have medical dispensaries staffed with nursing and allied health personnel, this type of fixed emergency life-support station can be set up with minimal additional cost and manpower. Its availability may encourage individuals to seek early medical care, thus shortening the delay caused by the patient's own indecision We may be able, however, to reduce morbidity and mortality through secondary prevention. Current approaches include the study of mechanisms of sudden death, development of techniques or methods in the early diagnosis and management of acute myocardial infarction, identification of individuals who are prone to sudden death, evaluation of preventive measures directed toward high-risk individuals, and early administration of antiarrhythmic drugs to patients with suspected or proven acute myo-ardial infarction.
1. Study of the mechanisms of sudden death is necessary because precise information concerning the mechanisms and clinical environment of sudden death is lacking. As indicated in the 1969-70 Annual Report of the Program Office of the Myocardial Infarction Research Units (MIRU) of the National Heart and Lung Institute (a public document, on file with the National Technical Information Service of the U. S. Department of Commerce, Springfield, Virginia), research in this area is being directed toward acquisition of information and insight concerning (a) external precipitating factors for myocardial infarction and sudden death; (b) physiologic and environmental settings in which they occur; (c) physiologic events that precede myocardial infarction and sudden cardiac death; (d) early physiologic consequences of acute illness; (e) pathologic changes and correlation with historical events and physiologic observations; (f) epidemiology of risk factors; (g) symptoms premonitory to impending myocardial infarction; and (h) prophylactic and early therapy to prevent myocardial infarction and sudden cardiac death.
2. Development of techniques and methods for early diagnosis and management of acute myocardial infarction prior to symptomatic onset would be worthwhile. Current diagnostic criteria depend on a typical history, evolutionary electrocardiographic changes, and serial enzyme abnormalities. By the time a patient complains of severe and prolonged chest pain, a significant degree of irreversible myocardial ischemia is probably already present. This early stage of acute myocardial infarction is a crucial period for the development of electrical instability, characterized by ventricular tachyarrhythmias.' If we could develop some techniques to detect the early occurrence of the lesion prior to the inception of symptoms and institute antiarrhythmic therapy accordingly, the incidence of ventricular fibrillation and sudden death might be drastically reduced.
3. Identification of individuals prone to sudden death is another important consideration as pointed out by Sidel, Acton, and Lown:53 "If a population at a very high risk can be selected with a high degree of sensitivity and specificity, the cost of prevention can be reduced and effectiveness increased. With appropriate collection and analysis of data, more discriminating methods of selection may be devised, and alternative strategies can be re-evaluated." It is indeed difficult, if not impossible, to identify a group of individuals at random who are susceptible to sudden death. Furthermore, at the present time there is really no practical means for such identification. From the available information, it would seem reasonable to direct our special attention toward certain groups of individuals:
(a) Those who have already had a previous attack of myocardial infarction.11' 14, 16. 22 In a combined series of more than 2,300 patients who died within 24 hours of onset of symptoms, 53-65% of them had a previous history of coronary artery disease and about 30% had a previous history of acute myocardial infarction. '6 (b) Those with recent onset, sudden recurrence, or crescendo type of angina pectoris. The incidence of sudden death among patients under any one of these three categories has been found to be higher than those with steady angina pectoris. (b) Self-injectioni of atropine or lidocaine. In a number of patients xx ith acute myocardial infarction, bradyarrhythmia observed during the early stage of the disease not only loxwers the cardiac output and systemic arterial pressure, but it also enhances the development of VPC.83 -4 When the ventricular rate is increased by administration of atropine. the likelihood of developing VPC decreases appreciablv.84 85 On the other hand, ventricular tachyarrhythmia, including frequent VPCs, may be successfully controlled by the administration of lidocaine. Intramuscular administration of this drug at a dose of 200-250 mg max raise the serum concentration to a satisfactory therapeutic lexel. which may be sustained over a period of 2-3 hours.N'r (Dunning AJ, Sehmers MOC: Personal communication.)
Proposals hax e been made to study the feasibility and efficacy of intramuscular selfadministration of an appropriate drug (atropine or lidocaine) by the patient at the onset of symptoms suggestixe of acute myocardial infarction."1 This approach may be particularly desirable for the high-risk coronary patients, each of whom may carry in his pocket at all times two automatic injectors, one with 2 mg of atropine and one with 250 mg of lidocaine. The patient may transmit the rate and regularity of his heart beats, by means of a special device, over the telephone to his family physician or a special receiving center. If he has a sloxv heart rate, under 60 beats per minute, indicating either a sinus bradveardia or heart block, he will be instructed to give himself atropine. On the other hand, if his heart rate is over 60 beats per minute, especially xvhen ectopic beats are present, he will be instructed to give himself lidocaine. This approach merits further study and deliberation because such a system brings w7ith it the possibility of antiarrhythmic therapy earlier than any other means suggested thus far. 
